Imunon Stock Quote IMNN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.07

Bid

1.06

Ask

1.09

Volume

287,289

1.055 Day's Range 1.16

0.48 52 Week Range 3.65

Market Cap

15.409M

Previous Close

1.14

Open

1.14

Last Trade

1.07

Last Trade Time

17:51:07

Financial Volume

$ 321,565

VWAP

1.1193

Average Volume (3m)

3,230,435

Shares Outstanding

14,400,889

Dividend Yield

PE Ratio

-1.45

Earnings Per Share (EPS)

-1.36

Revenue

Net Profit

-19.52M

Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to gen... Imunon Inc is developing new medicines that harness the building blocks of life to work in harmony with the body's immune system. It is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. Show more

Sector

Pharmaceutical Preparations

Industry

Health Care Diversified

Website

www.imunon.com

Headquarters

Dover, Delaware, USA

Founded

1982

Imunon Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker IMNN. The last closing price for Imunon was $1.14. Over the last year, Imunon shares have traded in a share price range of $ 0.48 to $ 3.65.

Imunon currently has 14,400,889 shares outstanding. The market capitalization of Imunon is $16.42 million. Imunon has a price to earnings ratio (PE ratio) of -1.45.

Form 4 - Statement of changes in beneficial ownership of securities

UPDATE - IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management

September 18th Event in New York City to Include a Review of the Opportunity for Investigational Therapy IMNN-001 (IL-12) to Treat Advanced Ovarian Cancer and Clinical Development Timeline...

IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management

September 18th Event in New York City to Include a Review of the Opportunity for Investigational Therapy IMNN-001 (IL-12) to Treat Advanced Ovarian Cancer and Clinical Development Timeline...

Form 8-K - Current report

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.04	-3.6036036036	1.11	1.21	1.03	260800	1.11419451	CS
4	-0.25	-18.9393939394	1.32	1.39	0.99	284225	1.13626013	CS
12	-0.07	-6.14035087719	1.14	3.65	0.9266	3230435	2.80561689	CS
26	0.25	30.487804878	0.82	3.65	0.7609	1535077	2.7549308	CS
52	-0.07	-6.14035087719	1.14	3.65	0.48	817259	2.65481524	CS
156	-0.89	-45.4081632653	1.96	3.65	0.48	433386	2.59169482	CS
260	-0.89	-45.4081632653	1.96	3.65	0.48	433386	2.59169482	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
LFLYLeafly Holdings Inc	$ 3.74 (108.94%)	4.61M
AENTAlliance Entertainment Holding Corporation	$ 2.88 (41.18%)	121.87k
TNONTenon Medical Inc	$ 6.60 (31.21%)	2.59M
AGBAAGBA Group Holding Ltd	$ 2.70 (27.96%)	1.28M
AEMDAethlon Medical Inc	$ 0.481 (23.33%)	8.37M
EJHE Home Household Service Holdings Ltd	$ 0.077 (-21.11%)	8.52M
KOPNKopin Corporation	$ 0.819 (-15.05%)	188.93k
VEROVenus Concept Inc	$ 0.7602 (-11.60%)	447.31k
NCINeo Concept International Group Holdings Ltd	$ 0.7461 (-11.18%)	1.55M
ARQArq Inc	$ 5.58 (-9.56%)	85.19k
EJHE Home Household Service Holdings Ltd	$ 0.077 (-21.11%)	8.52M
AEMDAethlon Medical Inc	$ 0.481 (23.33%)	8.37M
HSTHost Hotels and Resorts Inc	$ 18.53 (0.00%)	6.45M
LFLYLeafly Holdings Inc	$ 3.74 (108.94%)	4.61M
SQQQProShares UltraPro Short QQQ	$ 7.77 (0.13%)	4.33M